BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2026.
World J Gastrointest Oncol. Feb 15, 2026; 18(2): 115944
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.115944
Table 2 Overview of experimental and clinical studies assessing the effects of sevoflurane on gastric cancer biology and immune responses
Ref.
Key findings
Method
Chen et al[20]Increased miR-34a → Suppression of TGIF2 → Reduced EMT and invasionIn vitro
Liu and Chen[21]Tumor suppression via DLX6-AS1/epigenetic modulation through ZC3H13 knockdownIn vitro
Yong et al[23]Decreased FOXP3 expression in tumor cells leads to reduced invasionIn vitro
Yong et al[22]Increased CD4+CD25+FOXP3+ Treg cells; indicates immune modulationClinical study


Write to the Help Desk